Anmeldung erfolgt in Kürze...
Details werden geladen...
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw - The Economic Times
Biocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push for a shift beyond generics.
Ähnliche Seiten
Indian SME pharma firms see shift of orders from China; cost, quality concerns remain - The Economic Times
https://economictimes.indiatimes.com/small-biz/trade/exports/insights/indian-sme-pharma-firms-see-shift-of-orders-from-china-cost-quality-concerns-remain/articleshow/134754153.cmsCPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbook - The Economic Times
https://economictimes.indiatimes.com/small-biz/trade/exports/insights/cphi-milan-beyond-generics-how-indian-pharma-is-rewriting-its-global-playbook/articleshow/134788066.cmsAI Innovation in India: Turning business impact into industry recognition - The Economic Times
https://economictimes.indiatimes.com/et-awards/et-ai-awards-2027/ai-innovation-in-india-turning-business-impact-into-industry-recognition/articleshow/134704031.cmsConsumer companies score low on R&D spending amid innovation chorus - The Economic Times
https://economictimes.indiatimes.com/news/company/corporate-trends/consumer-companies-score-low-on-rd-spending-amid-innovation-chorus/articleshow/134646148.cmsTVS Motor’s Venu Srinivasan says India must bridge quality gap to make ‘Made in India’ a mark of trust - The Economic Times
https://economictimes.indiatimes.com/news/company/corporate-trends/tvs-motors-venu-srinivasan-says-india-must-bridge-quality-gap-to-make-made-in-india-a-mark-of-trust/articleshow/134690639.cms